Prognos Health Funding: $42M Raised, Series C (2017)
Prognos Health is a Healthtech company based in New York, NY. It has raised $42M in total funding. Latest round: Series C.
Prognos Health funding overview
Prognos Health is a Healthtech company based in New York, NY. Prognos Health has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2017. The round record for Prognos Health runs through 2017; nothing later has been disclosed. Investors on record include Cigna, GIS Strategic Ventures, Hermed, Hikma Ventures, Maywic, Merck Global Health Innovation Fund and 1 others. 7 distinct backers are named across the disclosed rounds.
Prognos Health at a glance
Total raised
$42M
Latest round
Series C
Latest round date
November 2017
Industry
Healthtech
Headquarters
New York, NY
Notable investors
Cigna, GIS Strategic Ventures, Hermed, Hikma Ventures, Maywic, Merck Global Health Innovation Fund, Safeguard Scientifics
Frequently asked about Prognos Health funding
How much has Prognos Health raised?
Prognos Health has raised $42M in total disclosed funding across the rounds on record.
Who has invested in Prognos Health?
Cigna, GIS Strategic Ventures, Hermed, Hikma Ventures, Maywic, Merck Global Health Innovation Fund are named among the investors backing Prognos Health.
What was the latest Prognos Health funding round?
The most recent disclosed round is a Series C, announced in November 2017.
Where is Prognos Health based?
Prognos Health is based in New York, NY.
What sector does Prognos Health operate in?
Prognos Health is tracked under Healthtech from New York, NY, with $42M in disclosed funding.
When did Prognos Health last raise?
The last disclosed Prognos Health round closed in November 2017 at Series C.
Prognos Health totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Healthtech companies in New York below to benchmark round size and investor mix.
